Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Saeki H, Oki E, Kashiwada T, Arigami T, et al. Re-evaluation of HER2 status in patients with HER2-positive advanced or recurrent gastric cancer refractory to trastuzumab (KSCC1604). Eur J Cancer 2018;105:41-49.
PMID: 30391779


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016